Invasive pulmonary aspergillosis usually occurs in severely immunocompromised or neutropenic patients. Six patients with invasive aspergillosis are described whose only defence impairment was underlying lung disease and corticosteroid treatment. Cough, fever, and sputum production were the usual reasons for presentation and four patients developed the sepsis syndrome. Radiographic findings included de novo cavitation in three patients and rapid radiographic progression in four. Aspergillus species were isolated from respiratory secretions of all patients early in the course of the disease. Treatment was effective in only two patients and the subsequent progress of the others was consistent with a chronic necrotising process. Invasive pulmonary aspergillosis is uncommon in patients with respiratory diseases receiving corticosteroids, but should be considered when pneumonia and cavitary infiltrates occur.
Patients and methods
Patients were included in this study if they had either a tissue diagnosis confirming invasive pulmonary aspergillus infection or, when tissue could not be obtained, respiratory secretions from which Aspergillus was cultured and a clinical history and radiographic or computed tomography findings highly suggestive of invasive disease-for example de novo cavitation with subsequent mycetomas. Patients with lymphoma or leukaemia and those receiving immunosuppressive drugs other than corticosteroids were excluded. Bronchoscopic specimens were obtained by lavaging the segment that was worst affected radiologically with 100 ml of normal saline. Transbronchial biopsy was possible in only two patients. Fungal cultures were made on Sabaroud-dextrose agar.
Patients had been managed at different times and in locations in the hospital, and no common environmental exposure was identified. Five of the cases are described in detail; case 6 has been reported previously. 3 Case reports PATIENT 1 A 75 year old white woman presented with chills, fever (38 4°C), increased cough and purulent sputum. Six weeks earlier, when she was admitted with a chronic cough, chest radiography had shown bilateral interstitial infiltrates, spirometry a restrictive pattern, and transbronchial biopsy pronounced interstitial fibrosis consistent with idiopathic pulmonary fibrosis. She was discharged taking prednisone 40 mg/day and antibiotics.
On readmission, she had a tachycardia and bilateral coarse rhonchi, and the chest radiograph showed left lower lobe consolidation. The white blood count was 18 with radiotherapy and six cycles of chemotherapy, completed six weeks before admission. One month before admission the patient presented with symptoms and magnetic resonance images were consistent with T6-8 cord compression, so he was started on dexamethasone 4 mg every 12 hours and local radiotherapy. The corticosteroids were increased to 24 mg/day and then reduced to 4 mg twice daily over one month.
On admission he complained of progressive weakness and decreased appetite. The white blood cell count was 3 1 x 109/l (52% neutrophils, 30% bands, 14% monocytes, 14% eosinophils). A chest radiograph showed a right paratracheal mass and infiltrate (fig 2a) and the patient was started on cefoxitin and gentamicin for presumed sepsis. Ten days later he was increasingly short of breath and a chest radiograph showed rapid progression of the infiltrate (fig 2b) . The white cell count was 6-8 x 109/1 with 68% neutrophils, 21% bands, 10% lymphocytes, and 1% atypical lymphocytes. He refused further treatment and died the next day. Sputum cultures showed Aspergillus fumigatus.
Postmortem examination disclosed no residual carcinoma, but there was extensive necrosis and cavitation within the mediastinum and right and left lung, with Aspergillus hyphae throughout these areas. Cultures of the lung revealed A fumigatus. 
SUMMARY OF CASE REPORTS
The salient features of our cases are summarised in the table. All the patients received antibiotics before the final diagnosis and in four patients pulmonary infiltrates developed after the start of antibiotic treatment. The chest radiograph showed new infiltrates in all cases. Radiographic changes progressed rapidly; a cavity developed in three patients and a mycetoma in two. Aspergillus was cultured from respiratory secretions from all patients and amphotericin B was started on the basis of the results of culture in four cases.
Discussion
A small but increasing number of cases of invasive aspergillus in patients with minimal immunosuppression have been reported."27 Invasive disease has been described in patients whose only underlying defect was pre-existing lung disease,' alcoholism,7-9 or prior influenza,'0 11 and occasionally in individuals with no apparent risk factor.4"1218 A recent report cited 25 minimally immunocompromised, nonneutropenic adults with invasive aspergillosis, of whom 10 had underlying lung disease and seven were receiving corticosteroids.4
Only a few cases similar to ours, receiving either low dose corticosteroids or brief courses of high doses for underlying lung disease, have been reported.6 1126 They include patients with chronic obstructive lung disease,'121 asthma,6202223 bronchospasm of undetermined aetiology,24 sarcoidosis,25 and berylliosis.26 A particularly disturbing feature was the progression from a clear radiograph to severe pneumonia and death in less than 10 days in patients 4 and 5, and from initial symptoms to death in two weeks and two months in patients 1 and 6.
Cases similar to ours with a more chronic necrotising process (patients 2 and 3) developing during moderate dose corticosteroid treatment or in the presence of underlying lung disease have also been described.28 Although tissue diagnosis of the disease was not possible in case 2, and necropsy after amphotericin B revealed no active disease in case 3, the clinical findings were highly suggestive of invasive disease. In both cases the computed tomography findings were consistent with de novo cavitation and mycetoma formation, as previously reported.2930
The development of invasive aspergillosis during long term treatment with low dose corticosteroids or short term treatment with higher doses raises the question of how corticosteroids affect the establishment of invasive parenchymal disease. The specific immune defences against Aspergillus are not fully delineated but appear to include both macrophages and neutrophils.3' 32 The response to inhaled conidia of Aspergillus is different from the mechanism controlling hyphal growth in tissue. Animal studies suggest the former activity to be mediated by macrophages and hyphal killing by polymorphonuclear cells. 3 32 The presence of either means of defence appears to be sufficient, at least in animal models. Glucocorticoids suppress the migra-tion of phagocytes and decrease the antifungal activity of monocytes and tissue macrophages as well as altering cell mediated immunity."336
In animal studies cortisone inhibits the conicidal activity of macrophages both in vitro and in vivo. Macrophage antifungal activity was suppressed in vitro at doses as low as 9 ng/ml of dexamethasone or 100 ng/ml of cortisone33 (physiological level 8-220 ng of cortisone over 24 hours with free cortisol concentrations of 0 8-28 ng/ml37). In vivo studies have shown a minimal neutrophil response to invasive aspergillus disease in animals treated with corticosteroids.3' The dose of corticosteroids causing failure of these defences in patients appears to depend on many host factors. Attempts to establish a threshold level of corticosteroid that puts patients at high risk for infection have been made in specific groups of patients. In patients receiving corticosteroids after renal transplantation the best predictor of infection was a daily dose greater than 125 mg/kg of prednisone. 38 In patients with liver transplants the total number of corticosteroid boluses had the best correlation with fungal infection.39 Cases like our own suggest that with underlying lung disease the risk occurs at much lower doses and fungal growth may be as explosive as that seen in patients with haematological disorders.
The first indication of infection in our patients was a positive culture from respiratory tract secretions, confirming an earlier report. 4 Potassium hydroxide preparations at the time of obtaining samples were not done. With saprophytic infestation conidiophores with conidia bearing vesicles should be seen.' Their presence, however, would not exclude distal invasive infection. The finding of hyphal elements when secretions are first examined does eliminate the possibility of contamination of secretions with spores and suggests invasion, but is not a substitute for the finding of hyphae in tissue as confirmation of the diagnosis. The clinical meaning of Aspergillus on smears or cultures of pulmonary secretions is frequently not clear. Aspergillus grew in cultures of sputum from 6-16% of patients with chronic obstructive lung disease and normal hosts. 4' 42 Positive bronchial lavage cultures appear to indicate infection more specifically, but their sensitivity has not been established. 43 In the setting of pneumonia in neutropenic patients the culture of Aspergillus in any respiratory secretion should lead to prompt investigation if there is any suspicion of invasive disease." Our results suggest this is also true in patients with lung disease.
Corticosteroids, in the doses our patients received, are used frequently in patients with asthma, chronic obstructive lung disease, interstitial lung disease, radiation pneumonitis, and various non-pulmonary disorders. The risk of opportunist infections in such settings is probably quite low, but should be considered when decisions are being made about the dose and duration of corticosteroid treatment. Aspergillus should be included in the differential diagnosis of pneumonia or cavitary infiltrates in such patients and the finding of Aspergillus in their respiratory secretions should not be dismissed as colonisation.
